Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438147 · ClinicalTrials.gov registry record · NA
Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms
A NA study, sponsored by Click Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT05438147 is a NA study that has completed, run by Click Therapeutics. The registered enrollment target is 114 participants.
The verdict
NCT05438147, a NA study, has completed, sponsored by Click Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
CT-100 is a platform that provides an interactive, software based therapeutic component that may be used as part of a multimodal treatment in supplementary or standalone prescription or nonprescription software-based digital therapeutics (PDT/DTx), being developed by Click Therapeutics, Inc.
Interventions
- OTHER Care-as-Usual
- OTHER CT-100 DiNaMo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2022-05-13 |
| Est. Completion | 2022-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05438147
The ClinicalTrials.gov registry entry for NCT05438147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Click Therapeutics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Care-as-Usual is the first listed.
NCT05438147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05438147 about?
NCT05438147 is a clinical study titled "Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms". CT-100 is a platform that provides an interactive, software based therapeutic component that may be used as part of a multimodal treatment in supplementary or standalone prescription or nonprescription software-based digital therapeutics (PDT/DTx), being developed by Click Therapeutics, Inc.
What is the current status of trial NCT05438147?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2022-05-13. Estimated completion is 2022-09-06.
What interventions are being tested in trial NCT05438147?
The interventions under investigation include: Care-as-Usual (OTHER), CT-100 DiNaMo (OTHER).
Who is sponsoring clinical trial NCT05438147?
This trial is sponsored by Click Therapeutics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.